Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,250.00
-170.00 (-2.29%)
At close: May 20, 2026
Market Cap205.37B +117.6%
Revenue (ttm)108.14B +5.8%
Net Income1.41B
EPS60.34
Shares Out27.68M
PE Ratio122.97
Forward PEn/a
Dividend30.00 (0.39%)
Ex-Dividend DateMar 3, 2026
Volume268,819
Average Volume514,928
Open7,160.00
Previous Close7,420.00
Day's Range7,090.00 - 7,410.00
52-Week Range3,285.00 - 15,960.00
Beta0.84
RSI33.23
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive ... [Read more]

Sector Healthcare
Founded 1965
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements